Filing Details

Accession Number:
0001968202-24-000084
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-05 16:01:49
Reporting Period:
2024-03-01
Accepted Time:
2024-03-05 16:01:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1187443 F Arthur Ryan 777 Old Saw Mill River Road
Tarrytown NY 10591
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-03-01 1 $967.50 18,381 No 4 S Direct
Common Stock Disposition 2024-03-01 1 $968.66 18,380 No 4 S Direct
Common Stock Disposition 2024-03-01 1 $969.18 18,379 No 4 S Direct
Common Stock Disposition 2024-03-01 4 $970.38 18,375 No 4 S Direct
Common Stock Disposition 2024-03-01 1 $971.75 18,374 No 4 S Direct
Common Stock Disposition 2024-03-01 2 $972.29 18,372 No 4 S Direct
Common Stock Disposition 2024-03-01 1 $974.78 18,371 No 4 S Direct
Common Stock Disposition 2024-03-01 2 $975.70 18,369 No 4 S Direct
Common Stock Disposition 2024-03-01 2 $976.81 18,367 No 4 S Direct
Common Stock Disposition 2024-03-01 2 $977.27 18,365 No 4 S Direct
Common Stock Disposition 2024-03-01 1 $978.09 18,364 No 4 S Direct
Common Stock Disposition 2024-03-01 1 $979.87 18,363 No 4 S Direct
Common Stock Disposition 2024-03-01 1 $980.21 18,362 No 4 S Direct
Common Stock Disposition 2024-03-01 15 $981.64 18,347 No 4 S Direct
Common Stock Disposition 2024-03-01 11 $982.67 18,336 No 4 S Direct
Common Stock Disposition 2024-03-01 12 $983.61 18,324 No 4 S Direct
Common Stock Disposition 2024-03-01 19 $984.45 18,305 No 4 S Direct
Common Stock Disposition 2024-03-01 10 $985.76 18,295 No 4 S Direct
Common Stock Disposition 2024-03-01 8 $986.58 18,287 No 4 S Direct
Common Stock Disposition 2024-03-01 4 $987.33 18,283 No 4 S Direct
Common Stock Disposition 2024-03-01 1 $988.30 18,282 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023.
  2. Represents volume-weighted average price of sales of 2 shares of Company stock on March 1, 2024 at prices ranging from $977.00 to $977.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.
  3. Represents volume-weighted average price of sales of 15 shares of Company stock on March 1, 2024 at prices ranging from $981.09 to $981.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.
  4. Represents volume-weighted average price of sales of 11 shares of Company stock on March 1, 2024 at prices ranging from $982.51 to $982.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.
  5. Represents volume-weighted average price of sales of 12 shares of Company stock on March 1, 2024 at prices ranging from $983.21 to $983.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.
  6. Represents volume-weighted average price of sales of 19 shares of Company stock on March 1, 2024 at prices ranging from $984.00 to $984.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.
  7. Represents volume-weighted average price of sales of 10 shares of Company stock on March 1, 2024 at prices ranging from $985.26 to $985.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.
  8. Represents volume-weighted average price of sales of 8 shares of Company stock on March 1, 2024 at prices ranging from $986.45 to $986.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.
  9. Represents volume-weighted average price of sales of 4 shares of Company stock on March 1, 2024 at prices ranging from $987.05 to $987.60. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.